Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Argus Research Downgrades Beyond Meat to Sell

Argus Research Downgrades Beyond Meat to Sell

Argus Research analyst Kristina Ruggeri downgrades Beyond Meat (NASDAQ:BYND) from Hold to Sell.

byBenzinga Newsdesk

December 9, 2022

1 minute read

Argus Research analyst Kristina Ruggeri downgrades Beyond Meat (NASDAQ:BYND) from Hold to Sell.

Analyst Ratings

Expert Ratings for Riskified

By Benzinga Insights

April 13, 5:00 PM

Analysts have provided the following ratings for Riskified (NYSE:RSKD) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

RSKD

SQZ Biotechnologies Publishes Preclinical Research Demonstrating SQZ AAC Platform’s Potential As An Effective Red Blood Cell-Derived Immunotherapy

By Benzinga Newsdesk

October 3, 6:46 AM

Activating Antigen Carriers (AACs) Shown Preclinically to Activate CD8 T Cells, Increase Their Tumor Infiltration and Drive Tumor Killing Demonstrated Improved Efficacy of AAC Therapy Through Combination with

SQZ

CareDx Sees FY23 Revenue $328M-$338M Vs $338.42M Est

By Happy Mohamed

February 27, 5:26 PM

2023 Guidance For the full year 2023, CareDx expects revenue to be in the range of $328 million to $338 million.

CDNA

News
Tech

Apple May Have Killed BlackBerry, But It’s Rising Again…In Movie Theaters This May

By Ananya Gairola

March 16, 5:28 AM

BlackBerry Ltd. (NYSE:AAPL) iPhone took over. What Happened: IFC Films has released the first trailer of “BlackBerry,” a…

AAPL

Argus Research Downgrades Beyond Meat to Sell

Related Posts

Expert Ratings for Riskified

SQZ Biotechnologies Publishes Preclinical Research Demonstrating SQZ AAC Platform’s Potential As An Effective Red Blood Cell-Derived Immunotherapy

CareDx Sees FY23 Revenue $328M-$338M Vs $338.42M Est

Apple May Have Killed BlackBerry, But It’s Rising Again…In Movie Theaters This May